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Abstract 
In this recent publication review the authors aimed to collect evidence of impact of nonsynonymous 
single nucleotide polymorphisms (nsSNP) in the renin–angiotensin–aldosterone system on patients’ 
phenotype not only regarding arterial hypertension and its complications, but also the impact on other 
diseases of interest outside the field of cardiovascular medicine. 
PubMed database records published between 2017–2020 were searched and all positive case-control 
studies or positive studies with human DNA were selected. 
The search identified 104 articles, of which 22 were included on the basis of the inclusion criteria. This 
paper presents the impact of 44 nsSNPs in panels for genes of renin, angiotensinogen, angiotensin-
-converting enzyme, angiotensin receptor and aldosterone on the clinical picture of investigated cohorts 
or on the peptide-protein interactions as consequence of nsSNPs.
Genetic variability in nsSNPs of the RAAS is involved in the pathogenesis of arterial hypertension and 
its complications, and surprisingly also in the pathogenesis of conditions not associated with elevated 
blood pressure, like neoplasms or inflammatory diseases. (Cardiol J)
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Introduction
The renin–angiotensin–aldosterone system 
(RAAS) is strongly involved in the pathogenesis of 
arterial hypertension, as well as in the occurrence 
of its complications. The diversity of the clinical 
course of this disease and the acceleration of target 
organ damage may depend not only on the pres-
ence of concomitant diseases, on environmental 
factors including lifestyle, quality of health care, 
utilization and adherence to proven preventive 
therapies, but also to some extent on genetic fac-
tors. The rapid development of genetics shows that 
nonsynonymous single nucleotide polymorphisms 
(SNP) are one of many types of human genome 
variability, which along with changes in epigenetic 
modulators (e.g., microRNA) or posttranscriptional 
modifications (e.g., methylation of DNA), play 
a role in shaping the final picture of the disease. Al-
though transcriptional errors which lead to a single 
nucleotide swap from a wild to a mutated variant 
usually have a spontaneous nature, they may be 
also inherited by descendants and be of importance 
even in fetal life. In 2017 it was suggested that 
the role of polymorphisms in the RAAS assessed 
in various population studies was overestimated 
during the “candidate gene era” and that there 
is a need to reconsider the clinical significance of 
RAAS variants for individuals in the framework 
of “precision medicine” [1]. Surprisingly, in the 
review prepared by Ji et al. [1], genetic variants of 
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ated with risk of cardiovascular diseases, but rather 
with abnormal thyroid function, schizophrenia, 
lead poisoning, fibrosis, angiotensin-converting-
enzyme (ACE) induced cough or with lipoprotein 
concentrations. Additionally, some new technolo-
gies enabled using artificial intelligence for the 
prediction of SNPs importance with regard to the 
interactions of their products (protein-peptide) 
and, potentially — for their altered function [2]. 
The aim of this study was to critically review the 
results of studies on the most investigated RAAS 
SNPs published since 2017 to date.
Methods
Two reviewers working independently ex-
tracted from PubMed database (www.pubmed.ncbi.
nlm.nih.gov) the relevant publications released 
between January 1, 2017 and November 30, 2020. 
Studies with the following keywords (as inclusion 
criteria): SNP, RAAS, renin, angiotensinogen, 
angiotensin, aldosterone, angiotensin-converting 
enzyme, angiotensin-receptor were extracted. Re-
views, meta-analyses, case reports, basic science 
studies with experimental medicinal compounds 
and studies performed in unique or specific popula-
tions were excluded. Only English-language, posi-
tive human studies or studies with human DNA 
were selected for this review of the latest reports 
on SNP in the RAAS. Figure 1 with flow-chart 
shows the selection of papers qualified for the 
present publication.
In the first step, two authors reviewed the 
abstracts and excluded those not meeting eligi-
bility criteria. The articles were included after 
two investigators independently recognized the 
article as eligible to this review. Differences 
between two reviewers were resolved by con-
sensus. Twenty-two articles referring to 44 SNPs 
were finally chosen for inclusion in this review 




The resequencing study conducted among 
the 1906 participants of the GenSalt study aimed 
to find SNP association with salt-sensitive arterial 
hypertension in a community from the Han Chi-
nese population with a habitually high Na-intake 
from rural areas [3]. Gene-based analyses were 
performed in 300 participants selected with the 
highest arterial pressure dietary response (mean 
+11.8 mmHg) and 300 with the lowest response 
(mean –1.1 mmHg). The probands in salt-sensitive 
group had higher mean age (41.6 vs. 38.2 years) 
than salt-resistant probands, and the rate of females 
was higher (52.5% vs. 35.6%). Seven RAAS genes 
with potential biological effect on blood pressure 
regulation were selected — renin-binding protein 
gene (RENBP), angiotensin I converting enzyme 2 
gene (ACE2) and angiotensin II type 1 recep-
tor gene (AGTR1) were in this number. Within 
50 single-nucleotide variants only low-frequen-
cy, missense SNP in RENBP gene described as 
rs78377269, present in exonic region of chromo-
some X (C to A substitution in 153941584 position) 
reached statistical significance in a single marker 
analysis (p = 0.03) after adjustment for multiple 
testing when studied subgroups were compared. 
Each copy of the minor allele corresponded to 
a 1.63 mmHg larger mean arterial pressure re-
sponse to dietary sodium intervention and a 2.21-
-fold increased odds of salt sensitivity (95% confi-
dence interval [CI] 1.10–4.42). The authors of that 
study do not exclude that the other SNPs tested in 
the study may explain, in aggregate, the phenom-
enon of salt-response hypertension.  
Since renin is associated with preeclampsia 
and eclampsia — genetic variability of its gene 
located on chromosome 1, was a subject of studies 
with mothers and their offspring, as well as moth-
ers alone in this respect in Chinese and Romanian 
centers, respectively.
Three SNPs were analyzed by Yu et al. [4] in 
a study which included 347 preeclampsia/eclampsia 
patients and 700 controls. The fetal heterozygotic 
genotype rs5707 in renin gene REN (AC) was sig-
nificantly (p = 0.004) associated with an increased 
risk of preeclampsia/eclampsia when accompanied 
by a mother’s body mass index ≥ 24 kg/m2 — odds 
ratio (OR) 2.75 (95% CI 1.5–5.06) [4]. In a study 
by Procopciuc et al. [5] where 87 pregnant women 
with preeclampsia were compared with 130 con-
Figure 1. Flow diagram of publications selection.
Identication Records identied through PubMed searching n = 104
Records after duplicates removed       n = 85
Records assessed for eligibility   n = 22
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trols also SNP rs2368564 (G83A) in REN with 
a heterozygotic form were significantly associated 
(p = 0.009) with late-onset preeclampsia [5]. 
The angiotensinogen panel
A different approach to genetic variability 
evaluation was applied in a study by Goswami [6] 
regarding angiotensinogen gene (AGT). That au-
thor validated 354 SNPs of AGT and determined 
their conservation degree in a 9-step scale. Using 
a computational modeling, 3-dimentional struc-
tures of wild-type and mutant AGT variants were 
generated. The nature of each of the 485 amino 
acids of this macromolecule was defined as exposed 
or as buried depending on what extent it is hidden 
in the protein structure space, moreover their 
functional or structural role for the protein was pre-
dicted. Three SNPs (rs1452925829, rs746613821 
and rs1162645963) were identified as being highly 
destabilizing for renin-angiotensinogen binding, 
they had also strongest impact on the change 
of the interface area between renin and angio-
tensinogen. It was proved earlier that a majority 
of diseases associated with nonsynonymous SNPs 
are caused by the instability of the proteins. The 
highest scores (0.808–0.919) for the prediction 
of the structure, function and post-translational 
modifications of human angiotensinogen were 
observed for rs1190025960, rs267598410, and 
rs1205199806 which lead to following swaps of 
amino acids in the indicated positions: G149R, 
R477G, and L162P, respectively. Substitutions 
of amino acids cause changes in some physical 
properties of angiotensinogen such as electrostatic 
potentials, nonpolar and polar solvation energy, 
mechanical energy and van der Waals forces. After 
AGT expression had been correlated with the sur-
vival of patients with four neoplasms, the author 
concluded that deregulation of angiotensinogen and 
des(angiotensin I)angiotensinogen is associated 
with survival outcomes in patients with gastric 
and breast cancer through their anti-angiogenic 
activity, as opposed to the pro-angiogenic action of 
angiotensin II with angiotensin II-receptor.
Returning from oncology to cardiovascular 
diseases, this next publication reestablishes the 
role of AGT variants and their haplotypes in the 
etiology of arterial hypertension and therefore 
Central illustration. The nonsynonymous single-nucleotide polymorphisms (nsSNPs) and spectrum of diseases 
described in this review; ACE — angiotensin converting enzyme; RAAS — renin–angiotensin–aldosterone system; 
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deserves attention [7]. The subject of interest in 
a study by Purkait et al. [7] performed in an Indian 
population were nine SNPs, both in 5’ untranslated 
regions (5’UTR), in exon and in intron regions 
of AGT. Four of them (rs11568020, rs5050 — in 
promoter and rs4762, rs699 — in exon 2) showed 
a positive association with arterial hypertension 
(p < 0.05), when 256 hypertensive cases were 
compared with 158 normotensive controls. Addi-
tionally, from the pool of 13 analyzed haplotypes, 
3 of them with 2–4/9 minor allele revealed in this 
study, a pro-hypertensive effect and 1 of them 
with all major allele — protective association with 
hypertension (p < 0.01). On the other hand, us-
ing multiple logistic regression analysis Khatami 
et al. [8] found a significant association of the two 
mentioned in the previous study SNPs — rs4762 
and rs699 with ischemic heart disease when in 
a dominant model 148 Iranian patients with coro-
nary artery disease (100% hypertensive as de-
scribed in the patient characteristics) were com-
pared with 135 normotensive controls without 
coronary artery disease — OR 1.91; 95% CI 
1.16–3.15; p = 0.01 and OR 1.8; 95% CI 1.1–2.93; 
p = 0.01, respectively [8]. The rs4762 and rs699 
were also among SNPs which underwent analysis 
for the purpose of verifying a hypothesis about 
their linkage with diabetic nephropathy. Mutated 
alleles of these SNPs presented an association with 
diabetic nephropathy with OR 10.25; p = 0.001 
and OR 22.21; p < 0.001, respectively, in a com-
parison of 47 Tunisian type 2 diabetic patients with 
nephropathy and 189 without this complication [9]. 
A cohort of 2872 white Australians from the 
Victorian Family Heart Study were enrolled in 
a program to test the association of systolic blood 
pressure with 88 SNPs in AGT, AGTR1, REN and 
aldosterone synthase gen (CYP11B2). This study 
by Scurrah et al. [10] revealed that in this group 
rs2468523 and rs2478544 at AGT presented sex-
specific association (not in women), and the pres-
ence of every minor allele resulted in an increase 
of systolic blood pressure in men by 1.58 and 
1.63 mmHg, respectively [10]. The next paper by 
Wu et al. [11] presents the problem of occupational 
exposure on lead, of lead-related hypertension and 
its association with rs7079 SNP. Although rs7079 
nucleotide is located in the untranslated region of 
the gene it is suggested that this DNA fragment is 
crucial for binding microRNA and that in this way 
influences AGT transcription and translation, and 
subsequently its serum concentration. The authors 
compared the frequency of minor allele and allele 
distribution between persons with a blood lead 
level < 200 µg/L and those with a blood lead level 
≥ 400 µg/L. Heterozygotic variant (CA) and ho-
mozygotic with minor allele (AA) variant of rs7079 
appeared more frequently in lead exposed than in 
unexposed individuals 47.4% vs. 33.3%; p = 0.02. 
Apart from this, homozygotes with major alleles 
(CC) had significantly higher blood concentration 
of angiotensinogen than heterozygotes (p = 0.01). 
This may be explained by observation that A allele 
decreased the binding between miRNA and the 
angiotensinogen gene. 
The ACE gene panel
In recent years some studies on ACE were 
focused on the association of its SNPs with an 
inflammatory process. It is reported in many stud-
ies that ACE has been associated with sarcoidosis. 
Although the group of Lahtela et al. [12, 13] did 
not confirm this link in their own study on Finnish 
patients, they indicated an interesting trait in the 
association of rs9905945 with prognosis in this 
disease. Using generally accepted criteria of World 
Association of Sarcoidosis and Other Granulomas 
(WASOG) they divided 188 patients from pulmo-
nary departments into two groups depending on 
the effects of treatment during a 2-year period: 
89 patients in whom the disease resolved and 97 
in whom it persisted. They discovered that the 
combination of rs9905945 in ACE and of previously 
reported HLA markers is helpful in predicting the 
course of this disease in a Finnish population more 
accurately than previously known. The C pheno-
type was statistically more frequent in the better 
prognosis group than the group with poor prog-
noses (79.8% vs. 66%; p = 0.035), and combining 
the frequencies of C phenotype with two defined 
HLA markers revealed a strong association with re-
solved versus persistent disease prognosis: 37.1% 
vs. 11.3%; p < 0.001; OR 4.61 (95% CI 2.15–9.86). 
Another interesting association of lung disease 
with ACE was tested in a population of Chinese 
children infected with Mycoplasma pneumoniae 
[14]. Polymorphism within ACE — rs4340 was 
analyzed together with SNPs within interleukin-6 
gene (IL-6) — rs1800795, and within nitric oxide 
synthase gene (NOS3) — rs1799983 and two other 
genes. The gene-gene interactions were tested us-
ing Multifactor Dimensionality Reduction (MDR) 
and cumulative genetic risk score approaches. The 
results of 715 blood samples (415 cases of myco-
plasmatic pneumonia and 300 healthy controls) 
showed that a combination of a major allele in ACE 
(D) with a minor allele in NOS3 (T) contribute 
to the genetic susceptibility of this germ-related 
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pneumonia in children in China: p =1.86 × 10–6, 
OR 3.44 (95% CI 2.014–5.888). 
ACE SNPs were also studied for associations 
with cardiovascular entities. A hypothesis that SNP 
of angiotensin-converting enzyme 2 gene (ACE2, 
mapped on chromosome X), may be associated with 
structural atrial fibrillation (AF) was verified in 300 
patients with this most frequent supraventricular 
arrhythmia and 300 arrhythmia-free controls (mean 
age in both groups 67.6 ± 12.5 and 66.1 ± 12.5, 
respectively; p = 0.133). In those Chinese patients 
the prevalence of arterial hypertension, diabetes 
mellitus, coronary artery disease, heart failure and 
nicotine-addiction were similar in the compared 
groups. However, the C allele in rs6632677 was 
more frequent in males, and when males were 
analyzed separately from females, the presence of 
the C allele increased significantly the risk of AF — 
OR 1.954 (95% 1.196–3.192) [15]. Additionally, an 
interaction was found between ACE2 and AGTR1 
in Chinese patients with this arrhythmia in MDR 
analysis in a 4-locus model (1 locus in ACE2 and 
3 loci in AGTR1). A 3-locus model with the same 
SNP in ACE2 together with SNP in the troponin 
I-interacting kinase gene (TNNI3K) and calmo-
dulin III gene (CALM3) was used by Kumar et al. 
[16] for risk prediction of hypertrophic and dilated 
cardiomyopathy (HCM and DCM). On the basis of 
the comparison of genotypes in 130 patients with 
HCM, 161 — with DCM and 236 controls, the 
authors concluded that these 3 polymorphisms 
significantly influenced both cardiomyopathy phe-
notypes. The 3-locus model predicted the risk of 
HCM and DCM with a prediction error of 23.4% and 
22.77%, respectively, with p = 0.03 and p = 0.04, 
respectively [16].
Quite a new association was described be-
tween three SNPs in the ACE gene located at 
chromosome 17 and the risk of sudden cardiac 
death (SCD) during a 64-month follow-up of 1852 
participants in the EVOLVE study (EValuation Of 
Cinacalcet Hydrochloride Therapy to Lower Car-
dioVascular Events), who were from two ancestry 
groups — European and African — and who were 
qualified for hemodialysis due to chronic kidney 
disease with secondary hyperthyroidism [17]. 
Three correlated SNPs — rs4335, rs4343 and 
rs4353 — in DNA from European ancestry patients 
were associated with a 26–27% reduction of SCD 
(OR 0.74 [95% CI 0.56–0.99], p = 0.004; OR 0.74 
[95% CI 0.55–0.99], p = 0.04; OR 0.73 [95% CI 
0.54–0.98], p = 0.036, respectively) and only one 
SNP — rs4318 — reduced the risk of SCD by 70% 
in the African ancestry patients (OR 0.3 [95% CI 
0.1–0.85], p = 0.03). Some ethnic differences in 
alleles distribution between European and African 
ancestry patients were found. In the former group, 
A is the minor allele in rs4335 and rs4343 had 
a frequency of 0.47 for both of them; whereas in 
the latter group it was G with a frequency of 0.23. 
For the third SNP — rs4353 — the same G was 
a minor allele in both ancestry groups.
Three SNPs in the ACE gene were investi-
gated among 125 genetic variants in a group of 1009 
participants to evaluate influence of genetic variant 
on the VO2peak level (as a measure of cardiorespi-
ratory fitness) in untrained people in China [18]. 
Only 1 of the 3 assessed SNPs — rs4295 — was 
associated with VO2peak (b = 0.87; p < 2.9 × 10–4) 
and it was responsible for 1.1% of interindividual 
variance in VO2peak.
A large-scale study (1024 hypertensive Chi-
nese patients and 956 normotensive ones) was 
focused on the impact of 34 SNPs of the ACE2 
gene located on chromosome X. Interestingly, 
it was determined that five of them (rs1514283, 
rs4646155, rs4646176, rs2285666, and rs879922) 
were associated significantly with hypertension in 
women, but not in men. For instance, in rs1514283 
the CC genotype and C allele were more frequent 
in hypertensive patients than in controls — 2.2% 
vs. 0.7%; OR 4.209; 95% CI 1.633–10.851; p < 0.05 
and 3.7% vs. 2.2%; p = 0.01. According to available 
research, this study reported for the first time that 
rs4646155 was associated with essential hyperten-
sion in women, and homozygotes with minor allele T 
were significantly more frequent in patients with 
hypertension than in controls — 1.9% vs. 0.7%; 
p = 0.01; OR 3.492; 95% CI 1.324–9.212 [19]. 
Interestingly enough, in another study, two of the 
above-mentioned SNPs (rs4646155 and rs4646176) 
together with rs2074192, rs2106809 were investi-
gated with regard to whether they could influence 
not only elevated blood pressure, but also their 
susceptibility to hypertensive left ventricular hy-
pertrophy (LVH) in Chinese patients. These four 
SNPs were genotyped in 289 patients with arterial 
hypertension with LVH and 358 controls without 
hypertrophy. The presence of minor allele T in 
rs2074192 and minor allele T in rs2106809 was 
significantly associated with LVH, with p = 0.005 
for both and OR 2.094, 95% CI 1.249–3.512; OR 
2.029, 95% CI 91.235–3.333, respectively [20]. 
Since angiotensin converting enzyme 2 inter-
acts with spike glycoprotein of the host to facilitate 
COVID-19 virus entry to the cells, Khalid et al. [21], 
carried out an in-silico study to determine the ef-
fect of SNPs at ACE2 gene on tertiary structure 
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of this protein and the impact of these SNPs on 
binding the virus. Two variants in ACE2 were 
identified as those which have an influence on the 
repulsion of ligands of the same negative charge 
(G405E, W461R), and the third was probably 
damaging to the protein (F588S). These findings 
may explain the differences in the course of severe 
acute respiratory syndrome coronavirus 2 (SARS- 
-CoV-2) infection-related disease during the cur-
rent pandemic [21]. 
Angiotensin receptor panel
Many polymorphisms listed in this panel were 
described already in previously cited articles, since 
SNPs of AGTR1 gene were quite often studied 
together with SNPs of ACE or AGT genes. An 
exception to this was a study on the association of 
rs5186 SNP (A1166C) with retinal vein occlusion; 
the study involved 69 patients and 82 controls. 
The minor allele C was significantly more fre-
quent (17.4% vs. 1.2%, p = 0.0001) in individuals 
with such complications within the ocular venous 
vasculature, which confirms earlier reports on 
the association of this SNP with other vascular 
events [22]. The rs5186 SNP was also studied with 
regard to its impact on development of diabetic 
nephropathy and presented positive association 
with this complication; p < 0.0001 [9]. The same 
SNP was studied in aforementioned EVOLVE 
trial, which presented a 31% increase in risk of 
composite endpoints (defined as death, nonfatal 
myocardial infarction, unstable angina leading to 
hospitalization, aggravation of heart failure or event 
related to peripheral artery disease) in patients 
qualified for dialysis — OR 1.31 (95% CI 1.15–1.49), 
p = 4.4 × 10–5. The molecular importance of this 
SNP may be explained by the fact, that AGTR1 is 
co-expressed with miR-155 in many tissues and 
the latter molecule represses the expression of 
AGTR1 only in the presence of a major A allele, 
but not in the presence of a minor C allele [23]. Ad-
ditionally, as the EVOLVE study proved, the minor 
C allele was found more frequently in patients of 
European ancestry (28%) than patients of African 
ancestry (5%) [17]. Another AGTR1 polymor-
phism — rs1492099 — was studied with respect 
to structural AF in a Chinese population group of 
300 patients with this arrhythmia and 300 controls 
[15]. The authors revealed a higher frequency of 
minor allele A in AF-group than in controls 14.2% 
vs. 8.8%, p = 0.004 with a 72.7% increased risk of 
arrhythmia for the minor allele — OR 1.727 (95% 
CI 1.154–2.487). Of the four SNPs in AGTR1 gene 
tested in the Victorian Family Study — rs12721297, 
rs385338, rs1800766 and rs275649 — only the first 
one presented an association with decreased values 
of systolic blood pressure with b(SE) –2.54(0.76)
mmHg [10]. Finally, as it was mentioned for ACE, 
some SNPs of AGTR gene played a critical role in 
breast cancer. One hundred sixty-one women in 
a North Indian breast cancer cohort were com-
pared with 152 healthy women, among others 
with respect to AGTR1 — rs5186 (A1166C) and 
ACE insertion/deletion (I/D) polymorphism. The 
results of analysis suggest a significant association 
of two tested polymorphisms with the risk of breast 
cancer: individuals harboring AC or CC genotype 
in AGTR1 together with DD genotype for ACE 
I/D polymorphism — present increased risk of 
breast cancer with OR 258 (95% CI 34.2–1944.4, 
p < 0.001) [24]. 
The aldosterone panel
An important rating enzyme in the process 
of the synthesis of aldosterone from cholesterol 
is aldosterone synthase (CYP11B2) and genetic 
variability in its gene is crucial for blood concentra-
tion of this hormone. One of the best investigated 
SNP of CYP11B2 gene is rs1799998 (T344C), but 
Qian et al. [25], added some new aspects to existing 
knowledge after a study on 96 adult patients with 
chronic kidney disease. They confirmed not only 
that homozygotes with major alleles (TT) have 
a significantly higher aldosterone concentration 
when compared with homozygotes with minor 
alleles (CC) — 247.5 ± 93.6 pg/mL vs. 190.0 ± 
81.7 pg/mL, p = 0.036, but also that the median 
annual decline of the estimated glomerular filtra-
tion rate during 1.5-year observation was signifi-
cantly higher in the TT group (5.2 ± 16.1%) than 
in the CC group (32.8 ± 82.5%) with p = 0.011 
[25]. Additionally, this group aimed to assess the 
impact of T344C on incidence of cardiovascular 
events defined as ST-segment elevation myocardial 
infarction, non-ST-segment elevation myocardial 
infarction and unstable angina in this group. The 
distribution of cardiovascular events was signifi-
cantly different from random, and it was highest in 
the TT group (25%), lowest in the CC group (0%), 
and intermediate in the CT group (7.8%), with 
p = 0.033. Lesser known polymorphisms of 
CYP11B2 were the subject of investigation in 1024 
patients with essential hypertension and 956 nor-
motensive controls [26]. Only one of seven SNPs 
selected for this study — rs542092383 — was 
found to increase the risk of essential hyperten-
sion — OR 3.48 (95% CI 1.407–8.597), p = 0.004. 
An interesting result was also obtained for the 
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next two SNPs — rs73715282 and rs7463212 
after adding them to the haplotype analysis with 
rs542092383. When major alleles in rs73715282 
and rs7463212 were accompanied by a minor al-
lele in rs542092383 (this was observed in 1.1% of 
patients with essential hypertension and in 0.2% 
of normotensive controls) the OR reached 5.729 
(95% CI 1.889–17.371), with p values < 0.0005.
Discussion
Some practitioners may be disappointed by 
a very weak impact of SNPs on phenotype in some 
publications mentioned in this review, e.g., sig-
nificant but small differences in allele frequency 
between various study groups. It is important 
to be aware, however, that such is the nature 
of SNPs, and a stronger association with clini-
cal manifestation is only possible when a higher 
number of unbeneficial SNP coexists in an ana-
lyzed individual. So, with respect to a benefit for 
public health, it is prudent to identify individuals 
at high risk of a given disease, hence it was pro-
posed to consider inclusion of so-called polygenic 
scores in this procedure. Such scores are already 
determined for the five most common diseases, 
including coronary artery disease, AF, diabetes 
mellitus type 2, inflammatory bowel disease and 
breast cancer [27]. Their potential advantage over 
the assessment based on clinical risk factors relies 
on a possibility to assess them directly after birth, 
so that primary prevention could be started at the 
earliest stages of the disease. However, a complex, 
multifactorial disease such as essential hyperten-
sion will probably be even more difficult to predict 
in childhood on the basis of genetic tests than the 
already studied diseases. 
Limitations of the study
This review has some limitations: first of 
all, this article was focused only on SNPs. Other 
polymorphisms like an insertion/deletion polymor-
phism or the polymorphism of variable number 
tandem repeats were ignored, although they also 
belong in genetic studies of proteins involved in the 
RAAS [28, 29]. Apart of this, epigenetic changes 
— DNA methylation, histone modifications or 
translational control with microRNA may alter 
the RAAS function. Furthermore, to some extent 
also enzymatic posttranslational modifications of 
proteins play a role in the function of the RAAS, 
although predisposition to protein destabilization 
depends also on nonsynonymous SNP as was ex-
plained by Goswami [6].
Conclusions 
In conclusion, individual susceptibility to hy-
pertension and its associations with genetic vari-
ability remain a subject of investigation, which also 
involve the proteins and enzymes not analyzed in 
this review. Generally, it should be emphasized that 
many regions of the genome are still unexplored 
and knowledge about the importance of underes-
timated regions will be deepened. Especially, the 
noncoding regions of the described genes deserve 
detailed research, as they are expected to consti-
tute 35 times more genetic material than the coding 
regions [30]. 
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